Variants in ACPP are associated with cerebrospinal fluid Prostatic Acid Phosphatase levels

Area of Science:

• Genetics
• Neuroscience
• Biochemistry

Background:

• Prostatic Acid Phosphatase (PAP) is an enzyme crucial for cell growth regulation and acts as a potential tumor suppressor.
• Its role in prostate cancer and expression in brain tissues highlight the importance of understanding its genetic regulation.

Purpose of the Study:

• To investigate the genetic factors influencing Prostatic Acid Phosphatase (PAP) levels in cerebrospinal fluid.
• To identify specific Single Nucleotide Polymorphisms (SNPs) associated with PAP regulation in the brain.

Main Methods:

• Genome-wide association study (GWAS) analyzing 5.8 million SNPs in 543 individuals across two datasets.
• Linear regression and meta-analysis using METAL with a stringent significance threshold (p < 5 × 10⁻⁸).
• Prioritization of candidate SNPs based on functional annotations and RegulomeDB scores.

Main Results:

• Identified 289 candidate SNPs associated with PAP cerebrospinal fluid levels after meta-analysis.
• Filtered to 13 SNPs that met criteria for biologically meaningful functional annotations, suggesting they are candidate causal alleles.
• These 13 SNPs are critical for understanding ACPP (gene encoding PAP) regulation and expression.

Conclusions:

• The identified SNPs provide novel insights into the genetic regulation of PAP in the brain.
• Findings have significant implications for understanding and potentially treating brain diseases, including neurodegenerative disorders and mental health conditions.
• This research opens avenues for exploring PAP's role in brain health and disease pathogenesis.